Drug Reaction with Eosinophilia and Systemic Symptoms (DReSS) Syndrome Associated with Liver Injury in Patient with Spondylarthritis: A Case Report

Eyleny Meisyah Fitri; Fatmah Azzuhra Lubis

doi:10.36452/jkdoktmeditek.v31i5.3902

Authors

Eyleny Meisyah Fitri Fakultas Kedokteran Universitas Indonesia – Rumah Sakit Umum Pusat Nasional dr. Cipto Mangunkusumo, Jakarta, Indonesia
Fatmah Azzuhra Lubis Fakultas Kedkteran Universitas Indonesia, Jakarta, Indonesia

DOI:

https://doi.org/10.36452/jkdoktmeditek.v31i5.3902

Keywords:

DReSS Syndrome, Drug Hypersensitivity, RegiSCAR

Abstract

Introduction: Drug reaction with eosinophilia and systemic symptoms syndrome or DReSS is a rare and life-threatening severe hypersensitivity reaction characterized by multiorgan involvement, with the liver as the common visceral manifestation. Approximately 10% of patients showed no changes in their eosinophil count. Sulfasalazine and non-steroidal anti-inflammatory drugs are frequently associated with DReSS. The diagnosis of this syndrome remains challenging due to the variety of clinical presentations. Case Illustration: We reported a 48-year-old woman who presented with pruritic generalized morbilliform eruption accompanied by facial edema and fever. Five weeks prior, she was treated with sulfasalazine and diclofenac sodium for spondyloarthritis. Her laboratory results showed elevated liver, suggesting drug-induced liver injury. DReSS syndrome was diagnosed by applying the European RegiSCAR. A favorable outcome and recovery of liver function are significantly seen after withdrawal of the suspected drugs, supportive treatment, and administration of systemic corticosteroid. Discussion: Sulfasalazine was one of the drugs frequently reported to cause DReSS syndrome. Liver involvement ranges from reversible elevation of liver function tests to hepatic necrosis. Withdrawal of causative drugs and administration of methylprednisolone were recommended, particularly for DReSS with liver involvement. Conclusions: DReSS syndrome can manifest with typical skin lesions and multiorgan involvement despite the absence of eosinophilia. The leading cause of mortality related to acute liver injury ranges from mild transaminase to acute liver failure. Prompt cessation of the culprit drug, immunosuppressive therapy, and a multidisciplinary approach might prevent further complications and mortality.

References

Calle AM, Aguirre N, Ardila JC, Cardona Villa R. DRESS syndrome: A literature review and treatment algorithm. World Allergy Organ J [Internet]. 2023 Mar [cited 2025 Jun 24];16:100673. Available from: https://doi.org/10.1016/j.waojou.2022.100673

Stirton H, Shear NH, Dodiuk-Gad RP. Drug reaction with eosinophilia and systemic symptoms (DReSS)/drug-induced hypersensitivity syndrome (DiHS)-readdressing the DReSS. Biomedicines [Internet]. 2022 Apr [cited 2025 Jun 24];10:999. Available from: https://doi.org/10.3390/biomedicines10050999

Hakim C, Melitas C, Nguyen E, Ngo K. Atypical manifestation of DRESS syndrome. Case Rep Gastrointest Med [Internet]. 2020 Apr [cited 2025 Jun 29];2020:e6863582. Available from: https://doi.org/10.1155/2020/6863582

Kremić Z, Mijušković Ž, Kandolf-Sekulović L. Dress syndrome - a case report. Serbian Journal of Dermatology and Venereology [Internet]. 2016 Jun [cited 2025 Jun 29];8. Available from: https://doi.org/10.1515/sjdv-2016-0009

Pinto Gouveia M, Gameiro A, Coutinho I, Pereira N, Cardoso JC, Gonçalo M. Overlap between maculopapular exanthema and drug reaction with eosinophilia and systemic symptoms among cutaneous adverse drug reactions in a dermatology ward. Br J Dermatol [Internet]. 2016 Dec [cited 2025 Jun 29];175:1274–83. Available from: https://doi.org/10.1111/bjd.14704

Shiohara T, Iijima M, Ikezawa Z, Hashimoto K. The diagnosis of a DRESS syndrome has been sufficiently established on the basis of typical clinical features and viral reactivations. Br J Dermatol [Internet]. 2007 May [cited 2025 Jun 26];156:1083–4. Available from: https://doi.org/10.1111/j.1365-2133.2007.07807.x

Amstutz U, Shear NH, Rieder MJ, Hwang S, Fung V, Nakamura H, et al. Recommendations for HLA-B*15:02 and HLA-A*31:01 genetic testing to reduce the risk of carbamazepine-induced hypersensitivity reactions. Epilepsia [Internet]. 2014 Mar [cited 2025 Jun 26] ;55:496–506. Available from: https://doi.org/10.1111/epi.12564

Duma S, Nikolovska S, Duma H, Breshkovska H, Dohcheva-Karajovanov I, Dimova M, et al. Drug rash with eosinophilia and systemic symptoms syndrome: case report and literature review. SEE J Immunol [Internet]. 2024 Jan [cited 2025 Jun 30];7:7–12. Available from: https://doi.org/10.3889/seejim.2024.6060

Jasmeen, Krishan P, Varma S, Kalra H, Vohra K. Sulfasalazine Induced DRESS Syndrome: A Review of Case Reports. J Adv Med Res [Internet]. 2016 Oct [cited 2025 Jun 29];1–11. Available from: https://doi.org/10.9734/BJMMR/2016/20558

Gomes R. DRESS Syndrome secondary to sulfasalazine: a case report. Saudi J Med [Internet]. 2022 Sep [cited 2025 Jun 25] ;07:1–4. Available from: https://www.researchgate.net/publication/363272724_DRESS_Syndrome_Secondary_to_Sulfasalazine_A_Case_Report

De A, Rajagopalan M, Sarda A, Das S, Biswas P. Drug reaction with eosinophilia and systemic symptoms: an update and review of recent literature. Indian J Dermatol [Internet]. 2018 Jan [cited 2025 Jun 30];63:30–40. Available from: https://doi.org/10.4103/ijd.IJD_582_17

Cabañas R, Ramírez E, Sendagorta E, Alamar R, Barranco R, Blanca-López N, et al. Spanish guidelines for diagnosis, management, treatment, and prevention of DRESS Syndrome. J Investig Allergol Clin Immunol[Internet]. 2020 Jan [cited 2025 Jun 25];30:229–53. Available from: https://doi.org/10.18176/jiaci.0480

Manieri E, Dondi A, Neri I, Lanari M. Drug rash with eosinophilia and systemic symptoms (DRESS) syndrome in childhood: a narrative review. Front Med [Internet]. 2023 Jul [cited 2025 Jun 29;10:1108345. Available from: https://doi.org/10.3389/fmed.2023.1108345

Kardaun SH, Sekula P, Valeyrie-Allanore L, Liss Y, Chu CY, Creamer D, et al. Drug reaction with eosinophilia and systemic symptoms (DRESS): an original multisystem adverse drug reaction. Results from the prospective RegiSCAR study. Br J Dermatol [Internet]. 2013 Nov [cited 2025 Jun 25];169:1071–80. Available from: https://doi.org/10.1111/bjd.12501

Janković S, Popovska-Jovičić B, Pavlović R, Živković-Zarić R. DRESS syndrome without eosinophilia induced by Carbamazepine: A case report. Hosp Pharm Int Multi J [Internet]. 2021 [cited 2025 Jun 30];8:1083–9. Available from: https://doi.org/10.5937/hpimj2103083J

Shear NH, Spielberg SP, Grant DM, Tang BK, Kalow W. Differences in metabolism of sulfonamides predisposing to idiosyncratic toxicity. Ann Intern Med [Internet]. 1986 Aug [cited 2025 Jun 30] ;105:179–84. Available from: https://doi.org/10.7326/0003-4819-105-2-179

Chaisrimaneepan N, Pruneda C, Elmassry M, Abdelnabi M. DRESS syndrome without eosinophilia presented with extensive skin rash and acute respiratory failure. Clin Case Rep [Internet]. 2024 May [cited 2025 Jun 26];12:e8905. Available from: https://doi.org/10.1002/ccr3.8905

Hirakawa S, Okazaki H, Sayama K, Tohyama M, Hashimoto K. Possible association of vascular endothelial growth factor with the development of edema in drug-induced hypersensitivity syndrome. J Dermatol [Internet]. 2011 Mar [cited 2025 Jun 25];38:292–4. Available from: https://doi.org/10.1111/j.1346-

Martinez-Cabriales SA, Shear NH, Gonzalez-Moreno EI. Liver involvement in the drug reaction, eosinophilia, and systemic symptoms syndrome. World J Clin Cases [Internet]. 2019 Mar [cited 2025 Jun 30];7:705–16. Available from: https://doi.org/10.12998/wjcc.v7.i6.705

Chiou CC, Yang LC, Hung SI, Chang YC, Kuo TT, Ho HC, et al. Clinicopathlogical features and prognosis of drug rash with eosinophilia and systemic symptoms: a study of 30 cases in Taiwan. J Eur Acad Dermatol Venereol [Internet]. 2008 Sep [cited 2025 Jun 30];22:1044–9. Available from: https://doi.org/10.1111/j.1468-3083.2008.02585.x

Kumar P, Saini S, Khan S, Surendra Lele S, Prabhakar BS. Restoring self-tolerance in autoimmune diseases by enhancing regulatory T-cells. Cell Immunol [Internet]. 2019 May [cited 2025 Jun 30];339:41–9. Available from: https://doi.org/10.1016/j.cellimm.2018.09.008

Mehmood B, Zaman AT, Zaman T. DRESS syndrome; drug reaction with eosinophilia and systemic symptoms: a case report and literature review. J Pak Assoc Dermatol [Internet]. 2024 [cited 2025 Jun 29];34:1062–9. Available from: https://www.jpad.com.pk/index.php/jpad/article/view/2949